Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Bio-Techne (TECH)
NASDAQ:TECH
Holding TECH?
Track your performance easily
TECH Stock Chart & Stats
Day’s Range― - ―
52-Week Range$61.16 - $85.57
Previous CloseN/A
Volume102.39K
Average Volume (3M)701.93K
Market Cap
$11.65B
Enterprise Value$13.09B
Total Cash (Recent Filing)$157.71M
Total Debt (Recent Filing)$343.77M
Price to Earnings (P/E)78.1
Beta1.10
Next Earnings
Feb 04, 2025EPS Estimate
0.39Last Dividend Ex-Date
Nov 08, 2024Dividend Yield0.44%
Share Statistics
EPS (TTM)0.94
Shares Outstanding158,891,800
10 Day Avg. Volume664,829
30 Day Avg. Volume701,928
Standard Deviation0.11
R-Squared0.40
Alpha-0.00412
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)9.94
Price to Cash Flow (P/CF)45.60
P/FCF Ratio53.20
Enterprise Value/Market Cap1.12
Enterprise Value/Revenue11.17
Enterprise Value/Gross Profit17.01
Enterprise Value/Ebitda44.23
Forecast
1Y Price Target
$83.50Price Target Upside9.26% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering6
Bio-Techne News
PremiumCompany Announcements
Bio-Techne Grants CFO Restricted Stock UnitsOwnership Overview
0.22% Insiders
39.39% Mutual Funds
2.34% Other Institutional Investors
34.21% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
ProductionRisks related to the company’s ability to manufacture goods and services
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
TECH FAQ
What was Bio-Techne’s price range in the past 12 months?
Bio-Techne lowest stock price was $61.16 and its highest was $85.57 in the past 12 months.
What is Bio-Techne’s market cap?
Bio-Techne’s market cap is $11.65B.
When is Bio-Techne’s upcoming earnings report date?
Bio-Techne’s upcoming earnings report date is Feb 04, 2025 which is in 20 days.
How were Bio-Techne’s earnings last quarter?
Bio-Techne released its earnings results on Oct 30, 2024. The company reported $0.42 earnings per share for the quarter, beating the consensus estimate of $0.382 by $0.038.
Is Bio-Techne overvalued?
According to Wall Street analysts Bio-Techne’s price is currently Undervalued.
Does Bio-Techne pay dividends?
Bio-Techne pays a Quarterly dividend of $0.316 which represents an annual dividend yield of 0.44%. See more information on Bio-Techne dividends here
What is Bio-Techne’s EPS estimate?
Bio-Techne’s EPS estimate is 0.39.
How many shares outstanding does Bio-Techne have?
Bio-Techne has 158,891,800 shares outstanding.
What happened to Bio-Techne’s price movement after its last earnings report?
Bio-Techne reported an EPS of $0.42 in its last earnings report, beating expectations of $0.382. Following the earnings report the stock price went up 7.472%.
Which hedge fund is a major shareholder of Bio-Techne?
Among the largest hedge funds holding Bio-Techne’s share is Mairs & Power Inc. It holds Bio-Techne’s shares valued at 216M.
---
Bio-Techne Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$83.50 (9.26% Upside)
$83.50 (9.26% Upside)
Blogger Sentiment
Bullish
TECH Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 45.6K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▲ 2.6%
Last 30 Days ▼ 5.4%
Last 30 Days ▼ 5.4%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
6.34%
12-Months-Change
Fundamentals
Return on Equity
7.05%
Trailing 12-Months
Asset Growth
-0.70%
Trailing 12-Months
Company Description
Bio-Techne
Bio-Techne Corporation (TECH) is a leading developer and manufacturer of high-quality biological reagents, instruments, and services for the research and clinical diagnostics markets. The company operates in the biotechnology sector, providing a wide range of products including proteins, antibodies, immunoassays, and other biological tools that are essential for scientific research and the development of new therapies. With a global presence, Bio-Techne supports scientists and clinicians by offering innovative solutions that advance life sciences and healthcare.
---
TECH Earnings Call
Q1 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
Bio-Techne's earnings call for Q1 2025 highlighted strong growth in diagnostics, spatial biology, and cell and gene therapy businesses. Despite challenges in China and operating margin pressures, the overall performance was aligned with expectations, showcasing stability and positive momentum across key growth areas.Read More>---
TECH Net revenue Breakdown
71.69% Protein Sciences
28.16% Diagnostics and Genomics
0.36% Other
---
TECH Stock 12 Month Forecast
Average Price Target
$83.50
▲(9.26% Upside)
Technical Analysis
Best Analysts Covering TECH
1 Year
1 Year Success Rate
21/33 ratings generated profit
1 Year Average Return
+14.25%
reiterated a buy rating 3 months ago
Copying Catherine Ramsey Schulte's trades and holding each position for 1 Year would result in 63.64% of your transactions generating a profit, with an average return of +14.25% per trade.
---